# Effect of Selective COX-2 Inhibition on Ulcer Healing

> **NCT00153673** · PHASE3 · COMPLETED · sponsor: **Chinese University of Hong Kong** · enrollment: 200 (actual)

## Conditions studied

- Arthritis
- Gastric Ulcer

## Interventions

- **DRUG:** celecoxib
- **DRUG:** Dologesics

## Key facts

- **NCT ID:** NCT00153673
- **Lead sponsor:** Chinese University of Hong Kong
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-02
- **Primary completion:** 2016-12-28
- **Final completion:** 2017-04-12
- **Target enrollment:** 200 (ACTUAL)
- **Last updated:** 2017-04-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00153673

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00153673, "Effect of Selective COX-2 Inhibition on Ulcer Healing". Retrieved via AI Analytics 2026-09-21 from https://api.ai-analytics.org/clinical/NCT00153673. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*